Univest
Univest
  • Markets

Venus Remedies Ltd. Hits Lower Circuit on BSE, 27 October 2026

  • October 8, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Venus Remedies lower circuit today on BSE

Venus Remedies lower circuit: on 27 October 2026 the BSE counter of Venus Remedies Ltd. (VENUSREM) was locked at Rs 1382.5, which is 5% below the previous close of Rs 1455.25. A one-sided order book of that kind leaves anyone wanting to trade the stock with little room, since sellers outnumber buyers at the band.

With the lock in place, the company carried a market cap of Rs 1945.23 crore. The session is worth tracking for short-term participants mostly for how thin the buying side was at the floor.

Table of Contents

Toggle
  • Key Takeaways
  • Key Market Data
  • Price Action and Trading Activity
  • Why Venus Remedies Ltd. Hit Lower Circuit
  • What the Venus Remedies Lower Circuit Means
  • Venus Remedies Ltd. Fundamentals and Valuation
  • Peer and Sector Context
  • Technical Snapshot
  • What Readers Should Know
  • Frequently Asked Questions
    • Why did Venus Remedies Ltd. hit lower circuit on 27 October 2026?
    • What was VENUSREM share price on 27 October 2026?
    • What was the lower circuit price for VENUSREM?
    • What is Venus Remedies Ltd.’s market cap and PE ratio?
    • Which exchange and data source were used?
    • Does hitting a lower circuit mean Venus Remedies Ltd. is a buy or a sell?
    • Can you buy or sell Venus Remedies Ltd. shares when the stock is at the lower circuit?
    • What happens the next trading session after a lower circuit?
    • What is the lower circuit limit set at for Indian stocks?

Key Takeaways

  • Venus Remedies Ltd. (VENUSREM) hit the lower circuit on BSE at Rs 1382.5 on 27 October 2026.
  • The session move was -5% against a previous close of Rs 1455.25.
  • Market capitalisation stood at Rs 1945.23 crore with a PE ratio of 15.99.
  • No official company announcement or verified catalyst was confirmed at the time of writing.
  • A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

Metric Value
Stock Venus Remedies Ltd.
Current Price / LTP Rs 1382.5
Day Move -5%
Previous Close Rs 1455.25
Day Open Rs 1528
Day High Rs 1528
Day Low Rs 1382.5
Lower Circuit Price Rs 1382.5
Lower Circuit Limit Rs 1382.5
Market Cap Rs 1945.23 crore
Selected Exchange BSE
PE Ratio 15.99

All figures above are as of 27 October 2026, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

The stock opened at Rs 1528 on BSE, well above the previous close of Rs 1455.25, and that open also marked the day high. From there it fell all the way to Rs 1382.5, the lowest print of the session and the same level as the circuit band, with no recovery above it.

The fall from the previous close works out to Rs 72.75, or 5%. All figures here come from BSE alone, so the open, range and band stay comparable with one another, since price bands and previous-close values can differ from one exchange to another. The band limit for the day was Rs 1382.5, the exact price the stock reached.

Why Venus Remedies Ltd. Hit Lower Circuit

Venus Remedies Ltd. reached the lower circuit after selling pressure pushed the price down to its exchange-defined band. No official company announcement or verified external catalyst was confirmed at the time of writing, so the move is best read through price action and market sentiment alone.

With no confirmed trigger on record, this note does not link the fall to earnings, a corporate action, sector news or market rumours. Should a confirmed disclosure emerge later, it belongs in a separate update.

Within the session, the floor stood at Rs 1382.5.

What the Venus Remedies Lower Circuit Means

A lower circuit is the lowest price a stock may trade at in a session under the exchange price band. For Venus Remedies Ltd., that floor was Rs 1382.5 on 27 October 2026.

Such bands exist to slow extreme moves and keep trading orderly. When the book is one-sided, orders pile up at the floor and few trades go through, so the quoted price shows where the band sits rather than where a seller could actually exit. It records what happened in the session, not a forecast of returns.

Venus Remedies Ltd. Fundamentals and Valuation

Market data offers more than the price move alone. Venus Remedies Ltd. carried a PE ratio of 15.99 and a PB ratio of 2.83, with book value of Rs 513.74 per share, EPS of 91.04 and a market cap of Rs 1945.23 crore. The company sits in the Healthcare sector, within Pharmaceuticals & Drugs. These are reference indicators only, not a buy, sell or hold view.

A PB ratio of 2.83 means the market priced the stock above its book value per share. Such a premium may reflect growth expectations, asset quality or simply limited trading in a smaller counter.

For anyone following lower circuit moves, ratios like these help separate the one-day price event from the wider financial profile. A sharp fall can draw attention, yet valuation and return measures still need their own review.

Peer and Sector Context

Venus Remedies Ltd. belongs to the Pharmaceuticals & Drugs industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.

Peer Company Market Cap PE PB ROE
Ind-Swift Laboratories Ltd. Rs 2986.18 crore 52.09 2.08 3.47%
Advanced Enzyme Technologies Ltd. Rs 2806.68 crore 16.92 1.69 11.43%
Hikal Ltd. Rs 2402.52 crore – 2.02 -3.97%
Fredun Pharmaceuticals Ltd. Rs 2338.74 crore 53.37 7.67 16.09%
Beta Drugs Ltd. Rs 2199.67 crore 42.37 5.03 18.78%

A dash in the PE column means no PE ratio was carried for that company in the source data, which happens when reported earnings are negative or have not been refreshed. Those companies are left out of the average below rather than counted as zero.

Venus Remedies Ltd.’s PE ratio was 15.99, compared with an available peer PE average of 41.19, calculated from the 4 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Want to know more? Log in to Univest for more stock insights.

Technical Snapshot

The technical snapshot adds context: RSI was 49.97, the 50-day moving average was 1608.05 and the 200-day moving average was 1481.58.

What Readers Should Know

The main confirmed fact is that Venus Remedies Ltd. touched the lower circuit on BSE at Rs 1382.5 on 27 October 2026, a 5% fall on the day.

The practical constraint after a session like this is execution. Sellers line up at the band while buyers are scarce, so an exit at the quoted price may not be possible. A second limit is that no official catalyst was confirmed at the time of writing.

Readers are better off treating a lower circuit as a market update rather than a standalone investment conclusion. The band points to heavy selling pressure in the near term, and any follow-up work should weigh business fundamentals, valuation, liquidity, risk and confirmed company disclosures.

Frequently Asked Questions

Why did Venus Remedies Ltd. hit lower circuit on 27 October 2026?

The stock reached its lower price band after selling pressure during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

What was VENUSREM share price on 27 October 2026?

The last traded price used in this article was Rs 1382.5 on BSE. That price matched the lower circuit price captured for the event.

What was the lower circuit price for VENUSREM?

The lower circuit price was Rs 1382.5. The stated exchange lower circuit limit was Rs 1382.5. The event numbers in this article are aligned to BSE.

What is Venus Remedies Ltd.’s market cap and PE ratio?

Venus Remedies Ltd.’s market cap was Rs 1945.23 crore. PE ratio was 15.99.

Which exchange and data source were used?

The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 27 October 2026.

Does hitting a lower circuit mean Venus Remedies Ltd. is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Venus Remedies Ltd. shares when the stock is at the lower circuit?

It is usually difficult. At the lower circuit, sell orders queue up with few buyers, so exiting at the quoted price may not be possible. Orders can stay unfilled until buying interest returns.

What happens the next trading session after a lower circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the lower circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Venus Remedies Ltd. the stated limit was Rs 1382.5. For this session, Venus Remedies Ltd. moved -5%.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply